Wenhua Du
Research Subjects
Wenhua Du has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Chuan Lin
Department of Biomedical Sciences, Institute for Medical Science, Jeonbuk National University Medical School, Jeonju, Korea
1 shared publication- Dao-Cheng Liu
State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, 400042, China
1 shared publication Guancheng Liu
Xinqiao Hospital, Military Medical University
1 shared publication- Hao Tan
State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, 400042, China
1 shared publication - Hua-Liang Xiao
State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, 400042, China
1 shared publication Jie Li
Xinqiao Hospital, Military Medical University
1 shared publication
Latest Publications
- Open Access
- 27 October 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-13
Glucose metabolic dysfunction surpasses dyslipidemia in driving hepatic steatosis and fibrosis: evidence from a nationally representative population
Evidence remains insufficient to clarify whether hyperglycemia or hyperlipidemia exerts a greater influence on the development of liver steatosis and fibrosis. Furthermore, it remains uncertain whether distinct glucose-lipid metabolic profiles are associated with an increased risk of these hepatic conditions. We used NHANES data to assess liver steatosis and fibrosis via Controlled Attenuation Parameter (CAP) and Liver Stiffness Measurement (LSM), then propensity-score weighted regression was used to access associations between seven glycolipid metabolic biomarkers and the two liver indices. Radar plots and network analysis were utilized to illustrate metabolic distribution patterns and delineate key metabolic signatures distinguishing four liver health phenotypes: Healthy Control, Steatotic Liver, Fibrotic Liver, and Combined Steatotic-Fibrotic Liver. Linear regression analyses were further conducted to compare the levels of steatosis and fibrosis across eight metabolic subgroups, categorized according to distinct combinations of dyslipidemia, dysglycemia, and insulin resistance. Lastly, a tree-based algorithm was employed to identify distinct glycolipid metabolic profiles associated with increased severity of hepatic steatosis and fibrosis. A total of 9698 individuals were included (mean age: 44.26 $$\:\pm\:$$ 20.80 years). Propensity score-weighted regression showed that TG, GLU, HbA1c, and HDL were significantly associated with both CAP and LSM, while TC and LDL were associated with CAP only. Radar plots and network analysis revealed that the steatosis-fibrosis group had the most adverse metabolic profile, with the lowest HDL, highest insulin, HbA1c, and GLU levels. TG and GLU consistently ranked as the top two central metabolic hubs across all liver groups, while HbA1c ranked third except in the steatotic-fibrotic group, where insulin resistance prevailed. Among subgroups with a single metabolic abnormality, CAP was highest in the insulin resistance (IR)-only group (B = 14.433, P < 0.001), followed by the dysglycemia-only group (B = 10.142, P < 0.001), and lowest in the dyslipidemia-only group. In IR-associated subgroups, CAP was significantly higher when IR co-occurred with dysglycemia (B = 57.393, P < 0.001) than with dyslipidemia (B = 53.635, P < 0.001). The triple abnormalities group exhibited the highest overall CAP (B = 79.811, P < 0.001) as well as the highest liver stiffness measurement (LSM) (B = 1.543, P < 0.001). Tree-based analysis further identified that CAP was highest in individuals with insulin ≥ 14.705 µU/mL and GLU ≥ 5.861 mmol/L, while LSM was highest in those with insulin between 17.1 and 28.205 µU/mL, HbA1c ≥ 6.15%, and GLU ≥ 7.861 mmol/L. Metabolic abnormalities related to hyperglycemia may be more closely associated with hepatic steatosis and fibrosis than those related to hyperlipidemia.- 27 October 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-13
Open AccessGlucose metabolic dysfunction surpasses dyslipidemia in driving hepatic steatosis and fibrosis: evidence from a nationally representative population
Evidence remains insufficient to clarify whether hyperglycemia or hyperlipidemia exerts a greater influence on the development of liver steatosis and fibrosis. Furthermore, it remains uncertain whether distinct glucose-lipid metabolic profiles are associated with an increased risk of these hepatic conditions. We used NHANES data to assess liver steatosis and fibrosis via Controlled Attenuation Parameter (CAP) and Liver Stiffness Measurement (LSM), then propensity-score weighted regression was used to access associations between seven glycolipid metabolic biomarkers and the two liver indices. Radar plots and network analysis were utilized to illustrate metabolic distribution patterns and delineate key metabolic signatures distinguishing four liver health phenotypes: Healthy Control, Steatotic Liver, Fibrotic Liver, and Combined Steatotic-Fibrotic Liver. Linear regression analyses were further conducted to compare the levels of steatosis and fibrosis across eight metabolic subgroups, categorized according to distinct combinations of dyslipidemia, dysglycemia, and insulin resistance. Lastly, a tree-based algorithm was employed to identify distinct glycolipid metabolic profiles associated with increased severity of hepatic steatosis and fibrosis. A total of 9698 individuals were included (mean age: 44.26 $$\:\pm\:$$ 20.80 years). Propensity score-weighted regression showed that TG, GLU, HbA1c, and HDL were significantly associated with both CAP and LSM, while TC and LDL were associated with CAP only. Radar plots and network analysis revealed that the steatosis-fibrosis group had the most adverse metabolic profile, with the lowest HDL, highest insulin, HbA1c, and GLU levels. TG and GLU consistently ranked as the top two central metabolic hubs across all liver groups, while HbA1c ranked third except in the steatotic-fibrotic group, where insulin resistance prevailed. Among subgroups with a single metabolic abnormality, CAP was highest in the insulin resistance (IR)-only group (B = 14.433, P < 0.001), followed by the dysglycemia-only group (B = 10.142, P < 0.001), and lowest in the dyslipidemia-only group. In IR-associated subgroups, CAP was significantly higher when IR co-occurred with dysglycemia (B = 57.393, P < 0.001) than with dyslipidemia (B = 53.635, P < 0.001). The triple abnormalities group exhibited the highest overall CAP (B = 79.811, P < 0.001) as well as the highest liver stiffness measurement (LSM) (B = 1.543, P < 0.001). Tree-based analysis further identified that CAP was highest in individuals with insulin ≥ 14.705 µU/mL and GLU ≥ 5.861 mmol/L, while LSM was highest in those with insulin between 17.1 and 28.205 µU/mL, HbA1c ≥ 6.15%, and GLU ≥ 7.861 mmol/L. Metabolic abnormalities related to hyperglycemia may be more closely associated with hepatic steatosis and fibrosis than those related to hyperlipidemia. - Open Access
- 15 April 2014
- Published by Elsevier in Military Medical Research
- Vol. 1 (1) , 4
Effect of intra-abdominal volume increment on kidneys in minipigs with intra-abdominal hypertension after hemorrhagic shock and resuscitation
- 15 April 2014
- Published by Elsevier in Military Medical Research
- Vol. 1 (1) , 4
Open AccessEffect of intra-abdominal volume increment on kidneys in minipigs with intra-abdominal hypertension after hemorrhagic shock and resuscitation
- 22 June 2012
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 64 (2) , 147-153
Mechanisms of Prostate Permeability Triggered by Microbubble-Mediated Acoustic Cavitation
The objective of this research was to study the mechanisms of opening of the blood–prostate barrier and increased permeability of prostate tissue induced by microbubble cavitation. Thirty-five rabbits were randomly divided into four study groups: (1) control group and groups exposed to (2) microbubble alone, (3) ultrasound alone, or (4) combined intervention (ultrasound + microbubble group). Evans blue (EB) tracer was used to gauge the changes of permeability of prostate tissue. Furthermore, light and electron microscopy analyses were conducted, as well as the western blot analysis of expression of gap junction (Cx43) protein. We observed that EB concentration in prostate tissue was significantly greater in the ultrasound + microbubble group compared with either intervention alone (p < 0.05, both comparisons). Furthermore, light microscopy of tissue samples from animals exposed to ultrasound + microbubble showed epithelial cell disarrangement, loss of interstitial structure, and thickness of fibrous stroma. In line with these findings, electron microscopy analysis demonstrated widening of cell gaps and broken cell connections, as well as more dense lysosomes and secretary granules, and mitochondrial swelling. These changes were absent in the animals exposed to microbubble or ultrasound alone. Finally, only combined treatment with microbubble or ultrasound significantly elevated expression of Cx43 (p < 0.05 vs. control group). In conclusion, increases of permeability of prostate tissue by acoustic cavitation appear to involve opening of tight junctions, widening of intracellular spaces, changes in the structure of acinar cell membrane, enhancement of vesicular transport, and loosening of fibrous stroma. Increased expression of cell gap junction protein will help to restore normal connections between cells and the blood–prostate barrier after the treatment.
- 22 June 2012
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 64 (2) , 147-153
Mechanisms of Prostate Permeability Triggered by Microbubble-Mediated Acoustic Cavitation
The objective of this research was to study the mechanisms of opening of the blood–prostate barrier and increased permeability of prostate tissue induced by microbubble cavitation. Thirty-five rabbits were randomly divided into four study groups: (1) control group and groups exposed to (2) microbubble alone, (3) ultrasound alone, or (4) combined intervention (ultrasound + microbubble group). Evans blue (EB) tracer was used to gauge the changes of permeability of prostate tissue. Furthermore, light and electron microscopy analyses were conducted, as well as the western blot analysis of expression of gap junction (Cx43) protein. We observed that EB concentration in prostate tissue was significantly greater in the ultrasound + microbubble group compared with either intervention alone (p < 0.05, both comparisons). Furthermore, light microscopy of tissue samples from animals exposed to ultrasound + microbubble showed epithelial cell disarrangement, loss of interstitial structure, and thickness of fibrous stroma. In line with these findings, electron microscopy analysis demonstrated widening of cell gaps and broken cell connections, as well as more dense lysosomes and secretary granules, and mitochondrial swelling. These changes were absent in the animals exposed to microbubble or ultrasound alone. Finally, only combined treatment with microbubble or ultrasound significantly elevated expression of Cx43 (p < 0.05 vs. control group). In conclusion, increases of permeability of prostate tissue by acoustic cavitation appear to involve opening of tight junctions, widening of intracellular spaces, changes in the structure of acinar cell membrane, enhancement of vesicular transport, and loosening of fibrous stroma. Increased expression of cell gap junction protein will help to restore normal connections between cells and the blood–prostate barrier after the treatment.